Cargando…

Inflammatory bowel disease in liver transplanted patients

Most common hepatobiliary manifestation of inflammatory bowel disease (IBD) are primary sclerosing cholangitis (PSC) and autoimmune hepatitis, ranking them as the main cause of liver transplantation (LT) in IBD setting. Course of pre-existing IBD after LT differs depending on many transplant related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filipec Kanizaj, Tajana, Mijic, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434427/ https://www.ncbi.nlm.nih.gov/pubmed/28566881 http://dx.doi.org/10.3748/wjg.v23.i18.3214

Ejemplares similares

The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
por: Paklar, Natasa, et al.
Publicado: (2023)

Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients
por: Mijic, Maja, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018)

Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Liver transplantation in hepatocellular carcinoma – should we perform downstaging?
por: Filipec Kanižaj, Tajana, et al.
Publicado: (2022)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Acute Liver Failure Caused by Secondary Hemophagocytic Lymphohistiocytosis After COVID-19 Vaccination – Case Report and Literature Review
por: Premec, Hrvoje, et al.
Publicado: (2023)

Liver transplantation in patients with neuroendocrine tumors: a case series and literature review
por: Ilić, Diana, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease – a growing public health problem
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2020)

Fecal microbiota transplantation – where are we?
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
por: Mikolašević, Ivana, et al.
Publicado: (2018)

Cardiovascular mortality in liver and kidney transplant recipients: A retrospective analysis from a single institution
por: Sertić, Zrinka, et al.
Publicado: (2021)

Drug-Induced Liver Injury Associated with Noni (Morinda citrifolia) Juice and Phenobarbital
por: Mrzljak, Anna, et al.
Publicado: (2013)

Use of machine learning models for identification of predictors of survival and tumour recurrence in liver transplant recipients with hepatocellular carcinoma
por: Bezjak, Miran, et al.
Publicado: (2023)

Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study
por: Madir, Anita, et al.
Publicado: (2019)

Constrictive pericarditis as a cause of refractory ascites after liver transplantation: A case report
por: Bezjak, Miran, et al.
Publicado: (2019)

Percutaneous Endovascular Treatment for Hepatic Artery Stenosis after Liver Transplantation: The Role of Percutaneous Endovascular Treatment
por: Vidjak, Vinko, et al.
Publicado: (2015)

Liver Disease During Pregnancy: A Challenging Clinical Issue
por: Mikolasevic, Ivana, et al.
Publicado: (2018)

External Validation of UDCA Response Score in Slovak and Croatian Patients with Primary Biliary Cholangitis
por: Gazda, Jakub, et al.
Publicado: (2021)

Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients
por: Gazda, Jakub, et al.
Publicado: (2021)

Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Liver regeneration as treatment target for severe alcoholic hepatitis
por: Virovic-Jukic, Lucija, et al.
Publicado: (2022)

The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C
por: Papic, Neven, et al.
Publicado: (2018)

Role of total pancreatectomy in the treatment of paraduodenal pancreatitis: A case report
por: Mikulić, Danko, et al.
Publicado: (2019)

Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography
por: Podrug, Kristian, et al.
Publicado: (2021)

Emergence of Echinococcus multilocularis in Central Continental Croatia: A Human Case Series and Update on Prevalence in Foxes
por: Balen Topić, Mirjana, et al.
Publicado: (2023)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease
por: Boicean, Adrian, et al.
Publicado: (2023)

Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients
por: Paštrovic, Frane, et al.
Publicado: (2021)

Liver Disorders in Inflammatory Bowel Disease
por: Uko, Victor, et al.
Publicado: (2012)

The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
por: Stojek, Magdalena, et al.
Publicado: (2021)

CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
por: Virović Jukić, Lucija, et al.
Publicado: (2021)

Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Basson, Abigail R, et al.
Publicado: (2020)

Fecal microbiota transplant – a new frontier in inflammatory bowel disease
por: Sunkara, Tagore, et al.
Publicado: (2018)

Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Levy, Alexander N., et al.
Publicado: (2019)

Do Semaphorins Play a Role in Development of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease?
por: Šamadan, Lara, et al.
Publicado: (2022)

Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease
por: Dragasevic, Sanja, et al.
Publicado: (2022)

Liver involvement in inflammatory bowel disease: What should the clinician know?
por: Losurdo, Giuseppe, et al.
Publicado: (2021)

Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
por: Mazza, Stefano, et al.
Publicado: (2021)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2rcjoe5gai34ramp70ni4rj74v